Exkivity remains available while Takeda works with the FDA on withdrawal timing, and the company said that patients currently taking the therapy will continue to have access after it is withdrawn.
MHE Staff
Advertisement
Articles by MHE Staff
The fight to put the consumer first in health care remains as many Americans feel the industry is still putting the mighty dollar ahead of patients.
As the need for rapid tests increase, the nation's largest non-profit patient safety organization evaluated seven COVID-19 rapid tests and found serious gaps in their usability.
New study shows opportunity exists to make healthcare more durable to further long-term gains in preparedness for emergencies like COVID-19.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Severe COVID-19 Increases Stroke Risk for Patients With Asthma
2
How Community Pharmacists Are Proactively Managing Patients’ Migraines | NCPA 2025
3
Pharmacists Help Patients Stay Adherent to COPD Therapy, Improving Overall Quality of Life
4
Guidelines Are Key for Treating Substance Use Disorder
5
